Mitchell Eric Horwitz | Scholars@Duke

Mitchell Eric Horwitz
Professor of Medicine

Allogeneic stem cell transplantation using umbilical cord blood grafts; Allogenic stem cell transplantation for Sickle Cell Disease; Prevention of acute graft versus host disease through donor stem cell graft manipulation; Improving immune recovery following alternative donor stem cell transplantation using donor graft manipulation or third party thymus transplantation.

Current Appointments & Affiliations

Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2016
Member of the Duke Cancer Institute, Duke Cancer Institute, Institutes and Centers 2003
Affiliate of the Regeneration Next Initiative, Regeneration Next Initiative, Institutes and Centers 2016

Contact Information

2400 Pratt St Suite 5000, DUMC Box 3961, Durham, NC 27710
2400 Pratt St Suite 5000, DUMC Box 3961, Durham, NC 27710
mitchell.horwitz@duke.edu (919) 668-1000

Background
Education, Training, & Certifications
- Medical Resident, Medicine, Northwestern University 1992 - 1995
- M.D., Rush University 1992
Duke Appointment History
- Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2013 - 2016
- Associate Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2010 - 2013
- Assistant Professor of Medicine, Medicine, Hematologic Malignancies and Cellular Therapy, Medicine 2003 - 2009
- Instructor, Temporary in the Department of Medicine, Medicine, Medical Oncology, Medicine 2003
Recognition
In the News
- DEC 5, 2018 Duke Health News
  
  Expanded Cord Blood Shows Potential for Use in Adult Bone Marrow Transplants
Research
Selected Grants
- Blood and Marrow Transplant Clinical Trials Network awarded by National Institutes of Health 2001 - 2024
- CSL964_2001 awarded by CSL Behring LLC 2019 - 2024
- INCB 18424-365 awarded by Incyte Corporation 2017 - 2023
- GNOS 201312100 awarded by Washington University in St. Louis 2017 - 2022
- A Multicenter, Randomized, Phase III Registratoin Trial of Transplantation of NiCord, Ex Vivo Expanded, Umbilical Cord Blood-derived, Stem and Progenitor Cells, versus Unmanipulated Umbilical Cord Blo awarded by Gamida Cell Ltd 2016 - 2021
- BMT CTN Protocol 1501 awarded by National Marrow Donor Program 2016 - 2021
- Transfusion Medicine and Hematology awarded by National Institutes of Health 1975 - 2021
- Phase I/II study to compare BEGEDINA vs conventional therapy in pts with GvHD awarded by Adienne SA 2015 - 2020
- BMT CTN Protocol 1506 awarded by Astellas Pharma Inc. 2017 - 2020
- Phase III RECRUIT Study CTN 1505 awarded by University of Texas Health Science Center at Houston 2015 - 2017
Publications & Artistic Works
Selected Publications
- Academic Articles
  - Cardones, AR, Sullivan, KM, Green, C, Chao, NJ, Rowe-Nichols, K, Bañez, LL, Burton, CS, Horwitz, ME, Long, GD, Rao, CL, Sarantopoulos, S, Sidhu-Malik, N, Sung, AD, and Hall, RP. "Interrater Reliability of Clinical Grading Measures for Cutaneous Chronic Graft-vs-Host Disease." Jama Dermatology (April 17, 2019). Full Text
  - Chen, Y-B, Le-Rademacher, J, Brazauskas, R, Kiefer, DM, Hamadani, M, DiPersio, JF, Litzow, MR, Craig, M, Horwitz, ME, Artz, AS, McClune, BL, Fernandez, HF, Duong, HK, Kobusingye, H, Proue, M, Drexler, RJ, Horowitz, MM, Shaw, BE, Miller, JP, Hosoba, S, Waller, EK, and Devine, SM. "Plerixafor alone for the mobilization and transplantation of HLA-matched sibling donor hematopoietic stem cells." Blood Advances 3, no. 6 (March 2019): 875-883. Full Text
  - Horwitz, ME, Wease, S, Blackwell, B, Valcarcel, D, Frassoni, F, Boelens, JJ, Nierkens, S, Jagasia, M, Wagner, JE, Kuball, J, Koh, LP, Majhail, NS, Stiff, PJ, Hanna, R, Hwang, WYK, Kurtzberg, J, Cilloni, D, Freedman, LS, Montesinos, P, and Sanz, G. "Phase I/II Study of Stem-Cell Transplantation Using a Single Cord Blood Unit Expanded Ex Vivo With Nicotinamide." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 37, no. 5 (February 2019): 367-374. Full Text
  - Spellecy, R, Tarima, S, Denzen, E, Moore, H, Abhyankar, S, Dawson, P, Foley, A, Gersten, I, Horwitz, M, Idossa, L, Joffe, S, Kamani, N, King, R, Lazaryan, A, Morris, L, Horowitz, MM, and Majhail, NS. "Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 24, no. 10 (October 2018): 2145-2151. Full Text
  - Micallef, IN, Stiff, PJ, Nademanee, AP, Maziarz, RT, Horwitz, ME, Stadtmauer, EA, Kaufman, JL, McCarty, JM, Vargo, R, Cheverton, PD, Struijs, M, Bolwell, B, and DiPersio, JF. "Plerixafor Plus Granulocyte Colony-Stimulating Factor for Patients with Non-Hodgkin Lymphoma and Multiple Myeloma: Long-Term Follow-Up Report." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 24, no. 6 (June 2018): 1187-1195. Full Text
  - Sullivan, KM, Horwitz, M, Osunkwo, I, Shah, N, and Strouse, JJ. "Shared Decision-Making in Hematopoietic Stem Cell Transplantation for Sickle Cell Disease." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 24, no. 5 (May 2018): 883-884. Full Text
  - Jones, RB, Martinez, C, Majhail, NS, Prestegaard, M, Maiers, M, Horwitz, M, and Komanduri, K. "Stem Cell Transplantation and Informatics: Current Considerations." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 24, no. 4 (April 2018): 659-665. (Review) Full Text
  - Grant, MJ, and Horwitz, ME. "HSCT-GAVE as a Manifestation of Chronic Graft versus Host Disease: A Case Report and Review of the Existing Literature." Case Reports in Transplantation 2018 (January 2018): 2376483-null. Full Text Open Access Copy
  - Sivaraj, D, Bacon, W, Long, GD, Rizzieri, DA, Horwitz, ME, Sullivan, KM, Kang, Y, Li, Z, Chao, NJ, and Gasparetto, C. "High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma." Bone Marrow Transplantation 53, no. 1 (January 2018): 34-38. Full Text
  - Huang, L-W, Bacon, W, Cirrincione, C, Peterson, B, Long, G, Rizzieri, D, Sullivan, KM, Corbet, K, Horwitz, M, Chao, N, Gasparetto, C, and Tuchman, SA. "Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma." Hematological oncology 35, no. 4 (December 2017): 752-759. Full Text
  - Soiffer, RJ, Kim, HT, McGuirk, J, Horwitz, ME, Johnston, L, Patnaik, MM, Rybka, W, Artz, A, Porter, DL, Shea, TC, Boyer, MW, Maziarz, RT, Shaughnessy, PJ, Gergis, U, Safah, H, Reshef, R, DiPersio, JF, Stiff, PJ, Vusirikala, M, Szer, J, Holter, J, Levine, JD, Martin, PJ, Pidala, JA, Lewis, ID, Ho, VT, Alyea, EP, Ritz, J, Glavin, F, Westervelt, P, Jagasia, MH, and Chen, Y-B. "Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 36 (December 2017): 4003-4011. Full Text
  - Poe, JC, Jia, W, Su, H, Anand, S, Rose, JJ, Tata, PV, Suthers, AN, Jones, CD, Kuan, PF, Vincent, BG, Serody, JS, Horwitz, ME, Ho, VT, Pavletic, SZ, Hakim, FT, Owzar, K, Zhang, D, Blazar, BR, Siebel, CW, Chao, NJ, Maillard, I, and Sarantopoulos, S. "An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD." Blood 130, no. 19 (November 2017): 2131-2145. Full Text
  - Stover, JT, Shaw, JR, Kuchibhatla, M, Horwitz, ME, and Engemann, AM. "Evaluation of Hematopoietic Stem Cell Mobilization Rates with Early Plerixafor Administration for Adult Stem Cell Transplantation." Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 23, no. 8 (August 2017): 1290-1294. Full Text
  - Anand, S, Thomas, S, Hyslop, T, Adcock, J, Corbet, K, Gasparetto, C, Lopez, R, Long, GD, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 23, no. 7 (July 2017): 1151-1157. Full Text
  - Barker, JN, Kurtzberg, J, Ballen, K, Boo, M, Brunstein, C, Cutler, C, Horwitz, M, Milano, F, Olson, A, Spellman, S, Wagner, JE, Delaney, C, and Shpall, E. "Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 23, no. 6 (June 2017): 882-896. (Review) Full Text
  - Scott, BL, Pasquini, MC, Logan, BR, Wu, J, Devine, SM, Porter, DL, Maziarz, RT, Warlick, ED, Fernandez, HF, Alyea, EP, Hamadani, M, Bashey, A, Giralt, S, Geller, NL, Leifer, E, Le-Rademacher, J, Mendizabal, AM, Horowitz, MM, Deeg, HJ, and Horwitz, ME. "Myeloablative Versus Reduced-Intensity Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndromes." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 35, no. 11 (April 2017): 1154-1161. Full Text
  - Sivaraj, D, Green, MM, Li, Z, Sung, AD, Sarantopoulos, S, Kang, Y, Long, GD, Horwitz, ME, Lopez, RD, Sullivan, KM, Rizzieri, DA, Chao, NJ, and Gasparetto, C. "Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 23, no. 2 (February 2017): 262-268. Full Text
  - Sung, A, and Horwitz, M. "Reply to Strahilevitz and Shapira." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (December 12, 2016).
  - Sung, AD, Sung, JAM, Thomas, S, Hyslop, T, Gasparetto, C, Long, G, Rizzieri, D, Sullivan, KM, Corbet, K, Broadwater, G, Chao, NJ, and Horwitz, ME. "Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial." Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America 63, no. 8 (October 2016): 999-1006. Full Text
  - Green, MMB, Chao, N, Chhabra, S, Corbet, K, Gasparetto, C, Horwitz, A, Li, Z, Venkata, JK, Long, G, Mims, A, Rizzieri, D, Sarantopoulos, S, Stuart, R, Sung, AD, Sullivan, KM, Costa, L, Horwitz, M, and Kang, Y. "Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery." Journal of Hematology & Oncology 9, no. 1 (August 17, 2016): 71-null. Full Text Open Access Copy
  - Flowers, CR, Costa, LJ, Pasquini, MC, Le-Rademacher, J, Lill, M, Shore, TB, Vaughan, W, Craig, M, Freytes, CO, Shea, TC, Horwitz, ME, Fay, JW, Mineishi, S, Rondelli, D, Mason, J, Braunschweig, I, Ai, W, Yeh, RF, Rodriguez, TE, Flinn, I, Comeau, T, Yeager, AM, Pulsipher, MA, Bence-Bruckler, I, Laneuville, P, Bierman, P, Chen, AI, Kato, K, Wang, Y, Xu, C, Smith, AJ, and Waller, EK. "Efficacy of Pharmacokinetics-Directed Busulfan, Cyclophosphamide, and Etoposide Conditioning and Autologous Stem Cell Transplantation for Lymphoma: Comparison of a Multicenter Phase II Study and CIBMTR Outcomes." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 22, no. 7 (July 2016): 1197-1205. Full Text Open Access Copy
  - Horwitz, ME. "Ex Vivo Expansion or Manipulation of Stem Cells to Improve Outcome of Umbilical Cord Blood Transplantation." Current hematologic malignancy reports 11, no. 1 (February 2016): 12-18. Full Text
  - Anderlini, P, Wu, J, Gersten, I, Ewell, M, Tolar, J, Antin, JH, Adams, R, Arai, S, Eames, G, Horwitz, ME, McCarty, J, Nakamura, R, Pulsipher, MA, Rowley, S, Leifer, E, Carter, SL, DiFronzo, NL, Horowitz, MM, Confer, D, Deeg, HJ, and Eapen, M. "Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation study." The Lancet. Haematology 2, no. 9 (September 2, 2015): e367-e375. Full Text
  - Horwitz, ME, and Frassoni, F. "Improving the outcome of umbilical cord blood transplantation through ex vivo expansion or graft manipulation." Cytotherapy 17, no. 6 (June 2015): 730-738. (Review) Full Text
  - Tuchman, SA, Bacon, WA, Huang, L-W, Long, G, Rizzieri, D, Horwitz, M, Chute, JP, Sullivan, K, Morris Engemann, A, Yopp, A, Li, Z, Corbet, K, Chao, N, and Gasparetto, C. "Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma." Journal of Clinical Apheresis 30, no. 3 (June 2015): 176-182. Full Text
  - Barker, JN, Fei, M, Karanes, C, Horwitz, M, Devine, S, Kindwall-Keller, TL, Holter, J, Adams, A, Logan, B, Navarro, WH, Riches, M, and RCI BMT 05-DCB Protocol Team, . "Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia." British journal of haematology 168, no. 3 (February 2015): 405-412. Full Text
  - Barker, JN, Fei, M, Karanes, C, Horwitz, M, Devine, S, Kindwall-Keller, TL, Holter, J, Adams, A, Logan, B, Navarro, WH, and Riches, M. "Results of a prospective multicentre myeloablative double-unit cord blood transplantation trial in adult patients with acute leukaemia and myelodysplasia." British Journal of Haematology 168, no. 3 (2015): 405-412. Full Text
  - Tuchman, SA, Bacon, WA, Huang, LW, Long, G, Rizzieri, D, Horwitz, M, Chute, JP, Sullivan, K, Engemann, AM, Yopp, A, Li, Z, Corbet, K, Chao, N, and Gasparetto, C. "Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma." Journal of Clinical Apheresis 30, no. 3 (January 1, 2015): 176-182. Full Text
  - Kelsey, CR, Scott, JM, Lane, A, Schwitzer, E, West, MJ, Thomas, S, Herndon, JE, Michalski, MG, Horwitz, ME, Hennig, T, and Jones, LW. "Cardiopulmonary exercise testing prior to myeloablative allo-SCT: a feasibility study." Bone marrow transplantation 49, no. 10 (October 2014): 1330-1336. Full Text
  - Horwitz, ME, Chao, NJ, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, McDonald, C, Waters-Pick, B, Stiff, P, Wease, S, Peled, A, Snyder, D, Cohen, EG, Shoham, H, Landau, E, Friend, E, Peleg, I, Aschengrau, D, Yackoubov, D, Kurtzberg, J, and Peled, T. "Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment." The Journal of Clinical Investigation 124, no. 7 (July 2014): 3121-3128. Full Text
  - Allen, JL, Tata, PV, Fore, MS, Wooten, J, Rudra, S, Deal, AM, Sharf, A, Hoffert, T, Roehrs, PA, Shea, TC, Serody, JS, Richards, KL, Jagasia, M, Lee, SJ, Rizzieri, D, Horwitz, ME, Chao, NJ, and Sarantopoulos, S. "Increased BCR responsiveness in B cells from patients with chronic GVHD." Blood 123, no. 13 (March 2014): 2108-2115. Full Text
  - Kanda, J, Long, GD, Gasparetto, C, Horwitz, ME, Sullivan, KM, Chute, JP, Morris, A, Shafique, M, Li, Z, Chao, NJ, and Rizzieri, DA. "Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 20, no. 2 (February 2014): 257-263. Full Text
  - Kelsey, CR, Scott, JM, Lane, A, Schwitzer, E, West, MJ, Thomas, S, Herndon, JE, Michalski, MG, Horwitz, ME, Hennig, T, and Jones, LW. "Cardiopulmonary exercise testing prior to myeloablative allo-SCT: A feasibility study." Bone Marrow Transplantation 49, no. 10 (January 1, 2014): 1330-1336. Full Text
  - Tricot, GJ, and Chao, NJ. "Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone." Bone Marrow Transplantation 48, no. 11 (November 1, 2013): 1444-1449. Full Text
  - Kanda, J, Kaynar, L, Kanda, Y, Prasad, VK, Parikh, SH, Lan, L, Shen, T, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, Winkel, S, McPherson, J, Kurtzberg, J, Chao, NJ, and Horwitz, ME. "Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment." Bone Marrow Transplantation 48, no. 7 (July 2013): 926-931. Full Text
  - Held, LA, Rizzieri, D, Long, GD, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Horwitz, ME, Chao, NJ, and Gasparetto, C. "A Phase I study of arsenic trioxide (Trisenox), ascorbic acid, and bortezomib (Velcade) combination therapy in patients with relapsed/refractory multiple myeloma." Cancer Investigation 31, no. 3 (March 2013): 172-176. Full Text
  - Kanda, J, Kaynar, L, Kanda, Y, Prasad, VK, Parikh, SH, Lan, L, Shen, T, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, Winkel, S, McPherson, J, Kurtzberg, J, Chao, NJ, and Horwitz, ME. "Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: Risk factors and response to treatment." Bone Marrow Transplantation 48, no. 7 (2013): 926-931. Full Text
  - Sung, AD, Grima, DT, Bernard, LM, Brown, S, Carrum, G, Holmberg, L, Horwitz, ME, Liesveld, JL, Kanda, J, McClune, B, and al, E. "Outcomes and costs of autologous stem cell mobilization with chemotherapy plus G-CSF vs G-CSF alone." Bone Marrow Transplantation (2013). Full Text Open Access Copy
  - Kanda, J, Chiou, L-W, Szabolcs, P, Sempowski, GD, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, McPherson, J, Hale, J, Livingston, JA, Broadwater, G, Niedzwiecki, D, Chao, NJ, and Horwitz, ME. "Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 18, no. 11 (November 2012): 1664-1676.e1. Full Text
  - Spasojevic, I, da Costa, LRS, Horwitz, ME, Long, GD, Sullivan, KM, Chute, JP, Gasparetto, C, Morris, A, Chao, NJ, and Rizzieri, DA. "Mini test dose of intravenous busulfan (busulfex(®)) in allogeneic non-myeloablative stem cell transplantation, followed by liquid chromatography tandem-mass spectrometry." Cancer Investigation 30, no. 9 (November 2012): 679-682. Full Text
  - Horwitz, ME, Long, G, Holman, P, Libby, E, Calandra, GC, and Schriber, JR. "Efficacy and safety of hematopoietic stem cell remobilization with plerixafor+G-CSF in adult patients with germ cell tumors." Bone Marrow Transplantation 47, no. 10 (October 2012): 1283-1286. Full Text
  - Eapen, M, Ahn, KW, Orchard, PJ, Cowan, MJ, Davies, SM, Fasth, A, Hassebroek, A, Ayas, M, Bonfim, C, O'Brien, TA, Gross, TG, Horwitz, M, Horwitz, E, Kapoor, N, Kurtzberg, J, Majhail, N, Ringden, O, Szabolcs, P, Veys, P, and Baker, KS. "Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 18, no. 9 (September 2012): 1438-1445. Full Text
  - Horwitz, ME, Chute, JP, Gasparetto, C, Long, GD, McDonald, C, Morris, A, Rizzieri, DA, Sullivan, KM, and Chao, NJ. "Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration." Bone Marrow Transplant 47, no. 8 (August 2012): 1051-1055. Full Text Link to Item
  - Chen, D-F, Prasad, VK, Broadwater, G, Reinsmoen, NL, DeOliveira, A, Clark, A, Sullivan, KM, Chute, JP, Horwitz, ME, Gasparetto, C, Long, GD, Yang, Y, Chao, NJ, and Rizzieri, DA. "Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors." Bone Marrow Transplant 47, no. 6 (June 2012): 817-823. Full Text Link to Item
  - Kanda, J, Horwitz, ME, Long, GD, Gasparetto, C, Sullivan, KM, Chute, JP, Morris, A, Hennig, T, Li, Z, Chao, NJ, and Rizzieri, DA. "Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation." Bone Marrow Transplant 47, no. 5 (May 2012): 700-705. Full Text Link to Item
  - Tolar, J, Deeg, HJ, Arai, S, Horwitz, M, Antin, JH, McCarty, JM, Adams, RH, Ewell, M, Leifer, ES, Gersten, ID, Carter, SL, Horowitz, MM, Nakamura, R, Pulsipher, MA, DiFronzo, NL, Confer, DL, Eapen, M, and Anderlini, P. "Fludarabine-Based Conditioning for Marrow Transplantation from Unrelated Donors in Severe Aplastic Anemia: Early Results of a Cyclophosphamide Dose Deescalation Study Show Life-Threatening Adverse Events at Predefined Cyclophosphamide Dose Levels." Biology of Blood and Marrow Transplantation 18, no. 7 (2012): 1007-1011. Full Text
  - Kelsey, CR, Horwitz, ME, Chino, JP, Craciunescu, O, Steffey, B, Folz, RJ, Chao, NJ, Rizzieri, DA, and Marks, LB. "Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors." Int J Radiat Oncol Biol Phys 81, no. 3 (November 1, 2011): 812-818. Full Text Link to Item
  - Kanda, J, Rizzieri, DA, Gasparetto, C, Long, GD, Chute, JP, Sullivan, KM, Morris, A, Smith, CA, Hogge, DE, Nitta, J, Song, K, Niedzwiecki, D, Chao, NJ, and Horwitz, ME. "Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning." Biol Blood Marrow Transplant 17, no. 6 (June 2011): 867-874. Full Text Link to Item
  - Wang, E, Hutchinson, CB, Huang, Q, Lu, CM, Crow, J, Wang, FF, Sebastian, S, Rehder, C, Lagoo, A, Horwitz, M, Rizzieri, D, Yu, J, Goodman, B, Datto, M, and Buckley, P. "Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature." American Journal of Clinical Pathology 135, no. 4 (April 2011): 525-540. (Review) Full Text
  - Craciunescu, OI, Steffey, BA, Kelsey, CR, Larrier, NA, Paarz-Largay, CJ, Prosnitz, RG, Chao, N, Chute, J, Gasparetto, C, Horwitz, M, Long, G, Rizzieri, D, and Sullivan, KM. "Renal shielding and dosimetry for patients with severe systemic sclerosis receiving immunoablation with total body irradiation in the scleroderma: cyclophosphamide or transplantation trial." International Journal of Radiation Oncology, Biology, Physics 79, no. 4 (March 2011): 1248-1255. Full Text
  - Horwitz, ME. "Reduced intensity versus myeloablative allogeneic stem cell transplantation for the treatment of acute myeloid leukemia, myelodysplastic syndrome and acute lymphoid leukemia." Curr Opin Oncol 23, no. 2 (March 2011): 197-202. (Review) Full Text Link to Item
  - Turbeville, S, Nicely, H, Rizzo, JD, Pedersen, TL, Orchard, PJ, Horwitz, ME, Horwitz, EM, Veys, P, Bonfim, C, and Al-Seraihy, A. "Clinical outcomes following hematopoietic stem cell transplantation for the treatment of mucopolysaccharidosis VI." Molecular Genetics and Metabolism 102, no. 2 (February 2011): 111-115. Full Text
  - Palmer, J, Goggins, T, Broadwater, G, Chao, N, Horwitz, M, Beaven, A, Sullivan, K, Coleman, RE, and Rizzieri, D. "Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma." Bone Marrow Transplantation 46, no. 6 (2011): 847-851. Full Text
  - Rizzieri, DA, Crout, C, Storms, R, Golob, J, Long, GD, Gasparetto, C, Sullivan, KM, Horwitz, M, Chute, J, Lagoo, AS, Morris, A, Beaven, A, Yang, Y, Peterson, B, Li, Z, and Chao, NJ. "Feasibility of low-dose interleukin-2 therapy following T-cell-depleted nonmyeloablative allogeneic hematopoietic stem cell transplantation from HLA-matched or -mismatched family member donors." Cancer Invest 29, no. 1 (January 2011): 56-61. Full Text Link to Item
  - Horwitz, ME, and Chao, N. "Umbilical cord blood transplantation for treatment of non-malignant disorders." Cellular Therapy and Transplantation 2, no. 7 (December 1, 2010). (Review) Full Text
  - Rizzieri, DA, Storms, R, Chen, D-F, Long, G, Yang, Y, Nikcevich, DA, Gasparetto, C, Horwitz, M, Chute, J, Sullivan, K, Hennig, T, Misra, D, Apple, C, Baker, M, Morris, A, Green, PG, Hasselblad, V, and Chao, NJ. "Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 16, no. 8 (August 2010): 1107-1114. Full Text
  - Crout, CA, Koh, L-P, Gockerman, JP, Moore, JO, Decastro, C, Long, GD, Diehl, L, Gasparetto, C, Niedzwiecki, D, Edwards, J, Prosnitz, L, Horwitz, M, Chute, J, Morris, A, Davis, P, Beaven, A, Chao, NJ, Ali-Osman, F, and Rizzieri, DA. "Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy." Cancer Invest 28, no. 6 (July 2010): 654-660. Full Text Link to Item
  - Horwitz, ME, and Chao, N. "Non-myeloablative umbilical cord blood transplantation." Best Practice & Research. Clinical Haematology 23, no. 2 (June 2010): 231-236. (Review) Full Text
  - Gasparetto, C, Gockerman, JP, Diehl, LF, de Castro, CM, Moore, JO, Long, GD, Horwitz, ME, Keogh, G, Chute, JP, Sullivan, KM, Neuwirth, R, Davis, PH, Sutton, LM, Anderson, RD, Chao, NJ, and Rizzieri, D. ""Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma." Biol Blood Marrow Transplant 16, no. 1 (January 2010): 70-77. Full Text Link to Item
  - DiPersio, JF, Stadtmauer, EA, Nademanee, A, Micallef, INM, Stiff, PJ, Kaufman, JL, Maziarz, RT, Hosing, C, Früehauf, S, Horwitz, M, Cooper, D, Bridger, G, Calandra, G, and 3102 Investigators, . "Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma." Blood 113, no. 23 (June 2009): 5720-5726. Full Text
  - de Castro, C, Adams, D, Rizzieri, D, Moore, J, Gockerman, J, Diehl, L, Horwitz, M, Edmonds, E, and Warzecho, J. "P134 A phase II pilot study of sorafenib in patients with myelodysplastic syndromes." Leukemia Research 33, no. SUPPL. 1 (May 1, 2009). Full Text
  - de Castro, C, Adams, D, Rizzieri, D, Moore, J, Gockerman, J, Diehl, L, Horwitz, M, Edmonds, E, and Warzecho, J. "P129 A pilot study of decitabine in combination with arsenic trioxide for patients with myelodysplastic syndromes." Leukemia Research 33, no. SUPPL. 1 (May 1, 2009). Full Text
  - Horwitz, ME, da Silva, TG, Eapen, M, and Horwitz, EM. "SURVIVAL FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION FOR CONGENITAL IMMUNODEFICIENCY AND METABOLIC DISORDERS." BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION 15, no. 2 (February 2009): 78-78. Full Text Link to Item
  - Rizzieri, DA, Dev, P, Long, GD, Gasparetto, C, Sullivan, KM, Horwitz, M, Chute, J, and Chao, NJ. "Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors." Bone Marrow Transplantation 43, no. 4 (February 2009): 327-333. Full Text
  - Qasim, W, Cavazzana-Calvo, M, Davies, EG, Davis, J, Duval, M, Eames, G, Farinha, N, Filopovich, A, Fischer, A, Friedrich, W, Gennery, A, Heilmann, C, Landais, P, Horwitz, M, Porta, F, Sedlacek, P, Seger, R, Slatten, M, Teague, L, Eapen, M, and Veys, P. "Allogeneic hematopoietic stem-cell transplantation for leukocyte adhesion deficiency." Pediatrics 123, no. 3 (2009): 836-840. Full Text
  - Horwitz, ME, Morris, A, Gasparetto, C, Sullivan, K, Long, G, Chute, J, Rizzieri, D, McPherson, J, and Chao, N. "Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 14, no. 5 (May 2008): 591-594. Full Text
  - Byrne, BJ, Horwitz, M, Long, GD, Gasparetto, C, Sullivan, KM, Chute, J, Chao, NJ, and Rizzieri, DA. "Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection." Bone Marrow Transplant 41, no. 1 (January 2008): 39-43. Full Text Link to Item
  - Uzel, G, Tng, E, Rosenzweig, SD, Hsu, AP, Shaw, JM, Horwitz, ME, Linton, GF, Anderson, SM, Kirby, MR, Oliveira, JB, Brown, MR, Fleisher, TA, Law, SKA, and Holland, SM. "Reversion mutations in patients with leukocyte adhesion deficiency type-1 (LAD-1)." Blood 111, no. 1 (2008): 209-218. Full Text
  - Horwitz, ME, Spasojevic, I, Morris, A, Telen, M, Essell, J, Gasparetto, C, Sullivan, K, Long, G, Chute, J, Chao, N, and Rizzieri, D. "Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics." Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation 13, no. 12 (December 2007): 1422-1426. Full Text
  - Horwitz, ME. "Sources of human and murine hematopoietic stem cells." Curr Protoc Immunol Chapter 22 (November 2007): Unit-22A.2. Full Text Link to Item
  - Hanson, KE, Reller, LB, Kurtzberg, J, Horwitz, M, Long, G, and Alexander, BD. "Comparison of the Digene Hybrid Capture System Cytomegalovirus (CMV) DNA (version 2.0), Roche CMV UL54 analyte-specific reagent, and QIAGEN RealArt CMV LightCycler PCR reagent tests using AcroMetrix OptiQuant CMV DNA quantification panels and specimens from allogeneic-stem-cell transplant recipients." Journal of Clinical Microbiology 45, no. 6 (June 2007): 1972-1973. Full Text
  - Rizzieri, DA, Koh, LP, Long, GD, Gasparetto, C, Sullivan, KM, Horwitz, M, Chute, J, Smith, C, Gong, JZ, Lagoo, A, Niedzwiecki, D, Dowell, JM, Waters-Pick, B, Liu, C, Marshall, D, Vredenburgh, JJ, Gockerman, J, Decastro, C, Moore, J, and Chao, NJ. "Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution." Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology 25, no. 6 (February 2007): 690-697. Full Text
  - Brenner, S, Ryser, MF, Choi, U, Whiting-Theobald, N, Kuhlisch, E, Linton, G, Kang, E, Lehmann, R, Rosen-Wolff, A, Rudikoff, AG, Farese, AM, Macvittie, TJ, Roesler, J, Horwitz, ME, and Malech, HL. "Polyclonal long-term MFGS-gp91phox marking in rhesus macaques after nonmyeloablative transplantation with transduced autologous peripheral blood progenitor cells." Molecular Therapy : the Journal of the American Society of Gene Therapy 14, no. 2 (August 2006): 202-211. Full Text
  - Bleesing, JJ, Souto-Carneiro, MM, Savage, WJ, Brown, MR, Martinez, C, Yavuz, S, Brenner, S, Siegel, RM, Horwitz, ME, Lipsky, PE, Malech, HL, and Fleisher, TA. "Patients with chronic granulomatous disease have a reduced peripheral blood memory B cell compartment." Journal of Immunology 176, no. 11 (2006): 7096-7103.
  - Horwitz, ME, and Sullivan, KM. "Chronic graft-versus-host disease." Blood Rev 20, no. 1 (January 2006): 15-27. (Review) Full Text Link to Item
  - Yamashita, K, Horwitz, ME, Kwatemaa, A, Nomicos, E, Castro, K, Sokolic, R, Foster, SF, Garofalo, M, Choi, U, Ryherd, M, Brown, MR, Leitman, SF, Wayne, AS, Fowler, DH, Bishop, MR, Childs, RW, Barrett, AJ, Pavletic, SZ, and Malech, HL. "Unique abnormalities of CD4⁺ and CD8⁺ central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis." Biology of Blood and Marrow Transplantation 12, no. SUPPL. 2 (2006): 22-30. Full Text
  - Roesler, J, Horwitz, ME, Picard, C, Bordigoni, P, Davies, G, Koscielniak, E, Levin, M, Veys, P, Reuter, U, Schulz, A, Thiede, C, Klingebiel, T, Fischer, A, Holland, SM, Casanova, J-L, and Friedrich, W. "Hematopoietic stem cell transplantation for complete IFN-gamma receptor 1 deficiency: a multi-institutional survey." The Journal of Pediatrics 145, no. 6 (December 2004): 806-812. Full Text
  - Chao, NJ, Koh, L-P, Long, GD, Gasparetto, C, Horwitz, M, Morris, A, Lassiter, M, Sullivan, KM, and Rizzieri, DA. "Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens." Biol Blood Marrow Transplant 10, no. 8 (August 2004): 569-575. Full Text Link to Item
  - Yamashita, K, Choi, U, Woltz, PC, Foster, SF, Sneller, MC, Hakim, FT, Fowler, DH, Bishop, MR, Pavletic, SZ, Tamari, M, Castro, K, Barrett, AJ, Childs, RW, Illei, GG, Leitman, SF, Malech, HL, and Horwitz, ME. "Severe chronic graft-versus-host disease is characterized by a preponderance of CD4(+) effector memory cells relative to central memory cells." Blood 103, no. 10 (May 2004): 3986-3988. Full Text
  - Bolan, CD, Yau, YY, Cullis, HC, Horwitz, ME, Mackall, CL, Barrett, AJ, Malech, HL, Rehak, NN, Wayne, AS, and Leitman, SF. "Pediatric large-volume leukapheresis: a single institution experience with heparin versus citrate-based anticoagulant regimens." Transfusion 44, no. 2 (February 2004): 229-238. Full Text
  - Horwitz, ME, Uzel, G, Linton, GF, Miller, JA, Brown, MR, Malech, HL, and Holland, SM. "Persistent Mycobacterium avium infection following nonmyeloablative allogeneic peripheral blood stem cell transplantation for interferon-gamma receptor-1 deficiency." Blood 102, no. 7 (October 1, 2003): 2692-2694. Full Text Link to Item
  - Brenner, S, Whiting-Theobald, NL, Linton, GF, Holmes, KL, Anderson-Cohen, M, Kelly, PF, Vanin, EF, Pilon, AM, Bodine, DM, Horwitz, ME, and Malech, HL. "Concentrated RD114-pseudotyped MFGS-gp91^phox vector achieves high levels of functional correction of the chronic granulomatous disease oxidase defect in NOD/SCID/β2-microglobulin^-/- repopulating mobilized human peripheral blood CD34⁺ cells." Blood 102, no. 8 (2003): 2789-2797. Full Text
  - Abo-Zena, RA, and Horwitz, ME. "Immunomodulation in stem-cell transplantation." Current Opinion in Pharmacology 2, no. 4 (2002): 452-457. Full Text
  - Savage, WJ, Bleesing, JJ, Douek, D, Brown, MR, Linton, GM, Malech, HL, and Horwitz, ME. "Lymphocyte reconstitution following non-myeloablative hematopoietic stem cell transplantation follows two patterns depending on age and donor/recipient chimerism." Bone Marrow Transplant 28, no. 5 (September 2001): 463-471. Full Text Link to Item
  - Horwitz, ME, Barrett, AJ, Brown, MR, Carter, CS, Childs, R, Gallin, JI, Holland, SM, Linton, GF, Miller, JA, Leitman, SF, Read, EJ, and Malech, HL. "Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft." The New England Journal of Medicine 344, no. 12 (March 2001): 881-888. Full Text
  - Barron, KS, Wallace, C, Woolfrey, A, Laxer, RM, Hirsch, R, Horwitz, M, Siegel, J, Filipovich, L, Wulffraat, N, Passo, M, and Rider, LG. "Autologous Stem Cell Transplantation for Pediatric Rheumatic Diseases." Journal of Rheumatology 28, no. 10 (2001): 2337-2358.
  - Horwitz, ME. "Stem-cell transplantation for inherited immunodeficiency disorders." Pediatr Clin North Am 47, no. 6 (December 2000): 1371-1387. (Review) Link to Item
  - Centola, M, Wood, G, Frucht, DM, Galon, J, Aringer, M, Farrell, C, Kingma, DW, Horwitz, ME, Mansfield, E, Holland, SM, O'Shea, JJ, Rosenberg, HF, Malech, HL, and Kastner, DL. "The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators." Blood 95, no. 10 (2000): 3223-3231.
  - Horwitz, ME, Malech, HL, Anderson, SM, Girard, LJ, Bodine, DM, and Orlic, D. "Granulocyte colony-stimulating factor mobilized peripheral blood stem cells enter into G1 of the cell cycle and express higher levels of amphotropic retrovirus receptor mRNA." Exp Hematol 27, no. 7 (July 1999): 1160-1167. Link to Item
- Conference Papers
  - Boelens, JJ, de Koning, C, Horwitz, ME, Sanz, G, Jagasia, M, Wagner, JE, Stiff, PJ, Hanna, R, Cilloni, D, and Nierkens, S. "Rapid and Robust CD4+and CD8+T-, NK-, B- and Monocyte Cell Reconstitution after Nicotinamide-Expanded Cord Blood Transplantation." 60th Annual Meeting of the American-Society-of-Hematology (ASH). San Diego, CA. December 1, 2018 - December 4, 2018.: AMER SOC HEMATOLOGY, November 29, 2018. Full Text Link to Item
  - Foster, Y, Grant, MJ, Thomas, SM, Cameron, B, Raiff, D, Corbet, K, Ferreri, C, and Horwitz, ME. "Treatment with Foscarnet after Allogenic Hematopoietic-Cell Transplant (AlloHCT) Is Associated with Long-Term Loss of Renal Function." 60th Annual Meeting of the American-Society-of-Hematology (ASH). San Diego, CA. December 1, 2018 - December 4, 2018.: AMER SOC HEMATOLOGY, November 29, 2018. Full Text Link to Item
  - Leventhal, JR, Galvin, JP, Mathew, J, Gallon, L, Ravindra, K, Horwitz, ME, Abecassis, M, and Ildstad, ST. "Use of a Processed Hematopoietic Stem Cell Product (FCRx) in Unmatched Related and Unrelated Donor - Recipient Pairs Is Associated with High Levels of Donor Chimerism and Donor-Specific Tolerance to Kidney Allografts." 60th Annual Meeting of the American-Society-of-Hematology (ASH). San Diego, CA. December 1, 2018 - December 4, 2018.: AMER SOC HEMATOLOGY, November 29, 2018. Full Text Link to Item
  - Horwitz, ME, Cilloni, D, Valcarcel, D, Frassoni, F, Boelens, J-J, Jagasia, M, Wagner, JE, Kuball, J, Koh, LP, Majhail, NS, Stiff, PJ, Hanna, R, Maziarz, RT, Hwang, WYK, Montesinos, P, Kurtzberg, J, and Sanz, G. "Nicord Single Unit Expanded Umbilical Cord Blood Transplantation (UCBT): Final Results of a Multicenter Phase I/II Trial." March 2018. Link to Item
  - Parikh, S, Brochstein, JA, Wease, S, Martin, PL, Horwitz, ME, Schwarzbach, A, and Kurtzberg, J. "A Novel Therapy for Sickle Cell Disease (SCD): Co-Transplantation of Nicord (R) [Ex Vivo Expanded Umbilical Cord Blood (UCB) Progenitor Cells with Nicotinamide] and an Unmanipulated Unrelated UCB Graft Leads to Successful Engraftment and Cure of Severe SCD." March 2018. Link to Item
  - Anand, S, Thomas, S, Corbet, K, Gasparetto, C, Long, GD, Lopez, R, Morris, AK, Rizzieri, DA, Sullivan, KM, Sung, AD, Sarantopoulos, S, Chao, NJ, and Horwitz, ME. "Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning." November 2017. Full Text
  - Anand, S, Thomas, S, Corbet, K, Gasparetto, C, Lopez, R, Long, GD, Morris, AK, Rizzieri, DA, Sarantopoulos, S, Sullivan, KM, Sung, AD, Chao, NJ, and Horwitz, ME. "Adult Umbilical Cord Blood Transplantation Using Myeloablative Total Body Irradiation, Fludarabine, and Thiotepa Conditioning." 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). San Diego, CA. December 3, 2016 - December 6, 2016.: AMER SOC HEMATOLOGY, December 2, 2016. Link to Item
  - Parikh, SH, Brochstein, J, Martin, PL, Horwitz, ME, Galamidi, E, Peleg, I, Goshen, U, Schwarzbach, A, Snyder, DA, Peled, T, and Kurtzberg, J. "Successful Engraftment of Donor Umbilical Cord Blood (UCB) Cells after Co-Transplantation of Nicord (R) (Ex Vivo Expanded UCB Progenitor Cells with Nicotinamide) and a Second Unmanipulated Cord Blood Unit after Myeloablative Chemotherapy in Pediatric Patients with Severe Sickle Cell Disease." 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). San Diego, CA. December 3, 2016 - December 6, 2016.: AMER SOC HEMATOLOGY, December 2, 2016. Link to Item
  - Soiffer, RJ, Kim, HT, McGuirk, J, Horwitz, ME, Johnston, L, Patnaik, MM, Rybka, W, Artz, A, Porter, DL, Shea, TC, Boyer, MW, Maziarz, RT, Jagasia, MH, Shaughnessy, PJ, Gergis, U, Safah, H, Reshef, R, DiPersio, JF, Stiff, PJ, Vusirikala, M, Szer, J, Holter, J, Levine, JD, Martin, PJ, Pidala, JA, Lewis, ID, Ho, VT, Alyea, EP, Ritz, J, Glavin, F, Westervelt, P, and Chen, Y-B. "A Prospective Randomized Double Blind Phase 3 Clinical Trial of Anti- T Lymphocyte Globulin (ATLG) to Assess Impact on Chronic Graft-Versus-Host Disease (cGVHD) Free Survival in Patients Undergoing HLA Matched Unrelated Myeloablative Hematopoietic Cell Transplantation (HCT)." 58th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH). San Diego, CA. December 3, 2016 - December 6, 2016.: AMER SOC HEMATOLOGY, December 2, 2016. Link to Item
  - Stephens, SJ, Thomas, S, Rizzieri, DA, Horwitz, ME, Chao, NJ, Engemann, AM, Lassiter, M, and Kelsey, CR. "Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity." October 2016. Full Text Open Access Copy
  - Huang, L-W, Bacon, W, Cirrincione, C, Peterson, B, Long, GD, Rizzieri, DA, Horwitz, ME, Sullivan, K, Corbet, K, Chao, NJ, Gasparetto, C, and Tuchman, S. "Efficacy of Autologous Stem Cell Transplantation in Older Multiple Myeloma Patients." March 2016. Full Text
  - Chen, Y-B, Le-Rademacher, J, Kiefer, DM, Hamadani, M, DiPersio, JF, Litzow, MR, Craig, M, Horwitz, ME, Artz, A, McClune, B, Waller, EK, Fernandez, HF, Duong, HK, Kobusingye, H, Proue, M, Drexler, RJ, Horowitz, MM, Miller, JP, and Devine, SM. "A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor for the Mobilization and Transplantation of HLA-Matched Sibling Donor Hematopoietic Stem Cells in Recipients with Hematological Malignancies." December 3, 2015. Link to Item
  - Scott, BL, Pasquini, MC, Logan, B, Wu, J, Devine, S, Porter, DL, Maziarz, RT, Warlick, E, Fernandez, HF, Alyea, EP, Hamadani, M, Bashey, A, Giralt, SA, Leifer, E, Geller, N, Le-Rademacher, J, Mendizabal, AM, Horowitz, MM, Deeg, HJ, and Horwitz, ME. "Results of a Phase III Randomized, Multi-Center Study of Allogeneic Stem Cell Transplantation after High Versus Reduced Intensity Conditioning in Patients with Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML): Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0901." December 3, 2015. Link to Item
  - Green, MMB, Horwitz, ME, Kang, Y, Chao, NJ, Long, GD, Rizzieri, D, Gasparetto, C, Sung, AD, Sarantopoulos, S, Li, Z, Corbet, K, Riggan-Stuelke, E, Sullivan, K, Wilson, B, Chhabra, S, Costa, LV, Mims, A, and Stuart, R. "Administration of Plerixafor (a CXCR4 antagonist) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation Enhances Platelet Recovery in a Phase I/II Trial." : Elsevier BV, February 2015. Full Text
  - Pasquini, MC, Le Rademacher, J, Flowers, C, Lill, M, Costa, LJ, Shore, TB, Vaughan, W, Craig, M, Freytes, CO, Shea, TC, Horwitz, ME, Fay, JW, Mineishi, S, Rondelli, D, Mason, J, Reddy, V, Braunschweig, I, Ai, W, Armstrong, E, Smith, A, Zhao, C, Elekes, A, Carreras, J, Kato, K, and Waller, EK. "Matched Pair Comparison of Busulfan/Cyclophosphamide/Etoposide (BuCyE) to Carmustine/Etoposide/Cytarabine/Melphalan (BEAM) Conditioning Regimen Prior to Autologous Hematopoietic Cell Transplantation (autoHCT) for Lymphoma." : Elsevier BV, February 2014. Full Text
  - Horwitz, ME, Stiff, PJ, Chao, NJ, Rizzieri, D, Long, G, Sullivan, K, Gasparetto, C, Chute, J, Morris, A, McDonald, C, Wease, S, Snyder, D, Galamidi-Cohen, E, Shoham, H, Landau, E, Friend, E, Kurtzberg, J, and Peled, T. "Nicord (R) Expanded Hematopoietic Progenitor Cells (HPC) Are Capable of Outcompeting the Unmanipulated (UM) Cord Blood Unit and of Prolonged Myeloid and Lymphoid Engraftment Following Myeloablative Dual Umbilical Cord Blood (UCB) Transplantation." February 2013. Full Text Link to Item
  - Sung, AD, Sung, JAM, Corbet, K, Hars, V, Lan, L, Broadwater, G, Zanter, A, Chute, J, Gasparetto, C, Long, G, Rizzieri, D, Sullivan, K, Chao, NJ, and Horwitz, ME. "Surgical Mask Usage Reduces the Incidence of Parainfleunza Virus 3 in Recipients of Stem Cell Transplantation." February 2013. Full Text Link to Item
  - Sung, AD, Sung, JAM, Corbet, K, Broadwater, G, Hars, V, Zanter, A, Chao, NJ, and Horwitz, ME. "Surgical Mask Usage Reduces the Incidence of Parainfluenza Virus 3 in Recipients of Stem Cell Transplantation." November 16, 2012. Link to Item
  - Sung, AD, Sung, JAM, Corbet, K, Broadwater, G, Hars, V, Zanter, A, Chao, NJ, and Horwitz, ME. "Surgical Mask Usage Reduces the Incidence of Parainfluenza Virus 3 in Recipients of Stem Cell Transplantation." November 16, 2012. Link to Item
  - Kanda, J, Kaynar, L, Kanda, Y, Prasad, VK, Parikh, SH, Rizzieri, DA, Long, GD, Sullivan, KM, Gasparetto, C, Chute, JP, Morris, A, Winkel, S, McPherson, J, Kurtzberg, J, Chao, NJ, and Horwitz, ME. "Use of Cyclosporine Is Associated with the Increase in Pre-Engraftment Syndrome After Myeloablative Dual Cord Blood Transplantation." February 2012. Full Text
  - Lill, M, Lim, S, Yeh, RF, Waller, E, Costa, LJ, Shore, T, Craig, M, Freytes, CO, Shea, TC, Mineishi, S, Rondelli, D, Horwitz, ME, Braunschweig, I, Fay, JW, Mason, JR, Yu, LH, Patil, S, Sun, Y, Armstrong, E, Elekes, A, Kato, K, and Vaughan, WP. "Dose Precision Using a Pretransplant Test PK of Intravenous Busulfan Prior to BuCyVP-16 Preparative Regimen in Lymphoma." : Elsevier BV, February 2012. Full Text
  - Bacon, WA, Long, GD, Rizzieri, DA, Horwitz, ME, Chute, JP, Sullivan, KM, Yopp, A, Johns, A, Chao, NJ, and Gasparetto, C. "Impact of High Dose Cyclophosphamide on the Outcome of Autologous Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma." November 18, 2011. Link to Item
  - Chao, NJ, Bernard, LM, Carrum, G, Fung, HC, Grima, DT, Holmberg, L, Brown, S, Horwitz, ME, Kanda, J, Liesveld, JL, McClune, B, Shaughnessy, P, and Tricot, GJ. "Differences in Stem Cell Collection Practices and Related Outcomes Between Centers That Conduct and Do Not Conduct Aphaeresis on Weekends." November 18, 2011. Link to Item
  - Chao, NJ, Grima, DT, Carrum, G, Holmberg, L, Fung, HC, Brown, S, Horwitz, ME, Bernard, LM, Kanda, J, Liesveld, JL, McClune, B, Shaughnessy, P, and Tricot, GJ. "Chemo-Mobilization Provides Superior Mobilization and Collection in Autologous Stem Cell Transplants but with Less Predictability and At a Higher Cost." November 18, 2011. Link to Item
  - Gasparetto, C, Bacon, WA, Doan, P, Rizzieri, DA, Horwitz, ME, Chute, JP, Sullivan, KM, Yopp, A, Li, Z, Chao, NJ, and Long, GD. "High Dose BCNU/Melphalan Preparative Regimen Doubles Event Free Survival of Myeloma Patients Undergoing Autologous Transplantation." November 18, 2011. Link to Item
  - Kanda, J, Rizzieri, DA, Long, GD, Gasparetto, C, Chute, JP, Sullivan, KM, Morris, A, McPherson, J, Livingston, JA, Broadwater, G, Niedzwiecki, D, Chao, NJ, and Horwitz, ME. "The Impact of Lymphocyte Subset Recovery At 3 Months on Progression-Free Survival After Myeloablative Allogeneic Stem Cell Transplantation." November 18, 2011. Link to Item
  - Kanda, J, Horwitz, ME, Long, GD, Gasparetto, C, Sullivan, KM, Chute, JP, Morris, A, Hennig, T, Chao, NJ, and Rizzieri, DA. "Outcomes of a 1-Day Nonmyeloablative Preparative Regimen for Primary Graft Failure After Allogeneic Stem Cell Transplantation." : Elsevier BV, February 2011. Full Text
  - Biernacki, MA, Okam, M, Shenoy, S, Krishnamurti, L, Horwitz, ME, Neuberg, D, Antin, JH, and Wu, CJ. "Long-Term Follow-up of Adults with Severe Sickle Cell Disease After Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning." November 19, 2010. Link to Item
  - Chiou, L-W, Kanda, J, Szabolcs, P, Sempowski, GE, Hale, J, Niedzwiecki, D, Broadwater, G, Chao, NJ, and Horwitz, ME. "A Comprehensive Comparison Immune Recovery In Adult Patients Following Allogeneic Umbilical Cord Blood, Matched Sibling and Matched Unrelated Donor Stem Cell Transplantation." November 19, 2010. Link to Item
  - Horwitz, ME, Gorak, E, Holman, P, Libby, E, Huebner, D, Mody, PD, and Schriber, JR. "Efficacy and Safety of Hematopoietic Stem Cell Remobilization with Plerixafor (Mozobil (R)) plus G-CSF In Adult Patients with Non-Hematologic Malignancies." November 19, 2010. Link to Item
  - Hutchinson, CB, Crow, JH, Huang, Q, Lu, CM, Sebastain, S, Rehder, C, Lagoo, AS, Goodman, B, Horwitz, ME, Rizzieri, DA, Datto, M, Buckley, P, and Wang, E. "Donor Cell Leukemia: A Clinicopathological Study of 9 Cases and a Comprehensive Review of Literature." November 19, 2010. Link to Item
  - Kanda, J, Long, GD, Gasparetto, C, Horwitz, ME, Sullivan, KM, Chute, JP, Morris, A, Li, Z, Chao, NJ, and Rizzieri, DA. "Prospective, Biological Randomized Study of T-Cell Depleted Nonmyeloablative Allogeneic Transplantation From HLA-Matched Related, Unrelated or Haploidentical Donors for Patients with Hematologic Malignancies." November 19, 2010. Link to Item
  - Gasparetto, C, Horwitz, ME, Gockerman, JP, de Castro, CM, Moore, JO, Smith, CA, Davis, P, Lassiter, M, Houser, L, Chao, NJ, and Rizzieri, D. "Campath-1H may have activity in the treatment of multiple myeloma." November 16, 2004. Link to Item
  - Ryser, MF, Brenner, S, Whiting-Theobald, N, Lehmann, R, Choi, U, Linton, GF, Kang, E, Rudikoff, AG, Farese, AM, MacVittie, TJ, Horwitz, ME, and Malech, HL. "Insertional analyses in rhesus monkey blood cells after non-myeloablative hematopoietic stem cell marking with a therapeutic onco-retroviral vector for X-linked chronic granulomatous disease." May 2004. Link to Item
  - Gasparetto, C, Chao, NJ, Horwitz, ME, Moore, JO, DeCastro, C, Gockerman, J, Sullivan, K, Rooney, B, Houser, L, Anderson, E, Hale, G, Toaso, B, and Rizzieri, DA. "Pharmacokinetics of subcutaneous alemtuzumab in a patient with myeloma." November 16, 2003. Link to Item
  - Goggins, TF, Rizzieri, DA, Prosnitz, R, Gasparetto, C, Long, G, Horwitz, ME, Sullivan, K, Morris, A, Thompson, M, Lassiter, M, Rowe, K, and Chao, NJ. "One day preparative regimen for allogeneic non-myeloablative stem cell transplantation (NMSCT) using 3-5/6 HLA matched related donors." November 16, 2003. Link to Item
  - Rizzieri, DA, Koh, LP, Long, GD, Lagoo, AS, Gasparatto, C, Vredenburgh, JJ, Buckley, PJ, Gong, G, Loftis, J, Rowe, K, Rooney, B, Niedzweicki, D, Waters-Pick, B, Eren, P, Vujevich, D, Catlin, C, Folz, RJ, Sullivan, K, Horwitz, ME, Morris, A, and Chao, NJ. "Clinical outcome and immune reconstitution following alemtuzumab T cell depleted nonmyeloablative allogeneic immunotherapy from HLA matched siblings." November 16, 2003. Link to Item

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.

Education, Training, & Certifications

Duke Appointment History

In the News

Selected Grants

Selected Publications

Academic Articles

Conference Papers